Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Recruiting · NCT07197944 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS | Digestive System Diseases, Intestinal Failure, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, digestive system disorder, disease, intestinal disorder, malabsorption syndrome, metabolic disease, short bowel syndrome, syndromic disease | Recruiting | Phase 3 | 2026-09-29 | NCT07197944 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zealand Pharma | 11 |
33 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.